0001209191-22-021393.txt : 20220328 0001209191-22-021393.hdr.sgml : 20220328 20220328203010 ACCESSION NUMBER: 0001209191-22-021393 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220324 FILED AS OF DATE: 20220328 DATE AS OF CHANGE: 20220328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hu Cynthia W. CENTRAL INDEX KEY: 0001364709 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40360 FILM NUMBER: 22777117 MAIL ADDRESS: STREET 1: 6440 WINDERMERE CITY: NORTH BETHESDA STATE: MD ZIP: 20852 FORMER NAME: FORMER CONFORMED NAME: Wong Cynthia DATE OF NAME CHANGE: 20060601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc. CENTRAL INDEX KEY: 0001813814 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 BUSINESS PHONE: (212) 220-6633 MAIL ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-24 0 0001813814 Mind Medicine (MindMed) Inc. MNMD 0001364709 Hu Cynthia W. C/O MIND MEDICINE (MINDMED), INC. ONE WORLD TRADE CENTER, SUITE 8500 NEW YORK NY 10007 0 1 0 0 Chief Legal Officer&Secretary Subordinate Voting Shares 2022-03-24 4 A 0 1200000 0.00 A 1200000 D Stock Option (Right to Buy) 1.18 2022-03-24 4 A 0 1560000 0.00 A 2027-03-23 Subordinate Voting Shares 1560000 1560000 D These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on December 6, 2022, with 1/48th vesting at the end of each month thereafter for the succeeding 36 months, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date. The option grant has an exercise price of $1.48 Canadian Dollars. This represents the exercise price in United States Dollars. 25% of the shares underlying the option shall vest and become exercisable on December 6, 2022; the remaining shares underlying the option shall vest and become exercisable with 1/48th of the total shares vesting at the end of each month thereafter for the succeeding 36 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date. /s/ Robert Barrow, Attorney-in-Fact 2022-03-28